Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
LZOEX Stock Summary
Top 10 Correlated ETFs
LZOEX
In the News
LZOEX Financial details
LZOEX Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
Metric | History | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0.6 | 0.41 | 0.42 | 0.41 | 0.38 | |
Net income per share | -1.88 | 3.25 | 2.77 | 3.62 | -3.87 | |
Operating cash flow per share | 2.52 | -2.95 | 2.1 | 1.11 | 1.89 | |
Free cash flow per share | 2.52 | -2.95 | 2.1 | 1.11 | 1.89 | |
Cash per share | 0.06 | 0.03 | 0.04 | 0.27 | 0.11 | |
Book value per share | 15.22 | 18.24 | 19.74 | 21.38 | 16.01 | |
Tangible book value per share | 15.22 | 18.24 | 19.74 | 21.38 | 16.01 | |
Share holders equity per share | 15.22 | 18.24 | 19.74 | 21.38 | 16.01 | |
Interest debt per share | 0 | 0 | 0 | 0 | 0 | |
Market cap | 158.77M | 247.57M | 241.85M | 243.28M | 195.97M | |
Enterprise value | 158.17M | 247.21M | 241.35M | 239.83M | 194.56M | |
P/E ratio | -8.78 | 5.85 | 6.7 | 5.16 | -3.89 | |
Price to sales ratio | 27.69 | 46.93 | 44.29 | 45.51 | 39.79 | |
POCF ratio | 6.56 | -6.45 | 8.85 | 16.81 | 7.97 | |
PFCF ratio | 6.56 | -6.45 | 8.85 | 16.81 | 7.97 | |
P/B Ratio | 1.09 | 1.04 | 0.94 | 0.87 | 0.94 | |
PTB ratio | 1.09 | 1.04 | 0.94 | 0.87 | 0.94 | |
EV to sales | 27.59 | 46.86 | 44.2 | 44.86 | 39.5 | |
Enterprise value over EBITDA | -7.48 | 6.22 | 7.05 | 5.25 | -3.76 | |
EV to operating cash flow | 6.53 | -6.44 | 8.84 | 16.57 | 7.92 | |
EV to free cash flow | 6.53 | -6.44 | 8.84 | 16.57 | 7.92 | |
Earnings yield | -0.11 | 0.17 | 0.15 | 0.19 | -0.26 | |
Free cash flow yield | 0.15 | -0.15 | 0.11 | 0.06 | 0.13 | |
Debt to equity | 0 | 0 | 0 | 0 | 0 | |
Debt to assets | 0 | 0 | 0 | 0 | 0 | |
Net debt to EBITDA | 0.03 | -0.01 | -0.01 | -0.08 | 0.03 | |
Current ratio | 0.12 | 0.09 | 0.18 | 0.15 | 0.18 | |
Interest coverage | 0 | 0 | 0 | 0 | 0 | |
Income quality | -1.34 | -0.91 | 0.76 | 0.31 | -0.49 | |
Dividend Yield | 0.16 | 0.04 | 0.07 | 0.07 | 0.14 | |
Payout ratio | -1.44 | 0.25 | 0.46 | 0.38 | -0.54 | |
Sales general and administrative to revenue | 0.47 | 0.51 | 0.66 | 0.73 | 0.72 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 25.4 | 36.55 | 35.1 | 41.74 | 37.36 | |
ROIC | 0 | 0 | 0 | 0 | 0 | |
Return on tangible assets | -0.11 | 0.16 | 0.13 | 0.15 | -0.21 | |
Graham Net | -2.51 | -2.32 | -1.63 | -2.42 | -2.07 | |
Working capital | -22.74M | -28.51M | -18.36M | -30.29M | -23.68M | |
Tangible asset value | 146.2M | 237.28M | 256.75M | 278.17M | 208.33M | |
Net current asset value | -22.74M | -28.51M | -18.36M | -30.29M | -23.68M | |
Invested capital | 0 | 0 | 0 | 0 | 0 | |
Average receivables | 1.12M | 1.12M | 843.51K | 961.43K | 934.84K | |
Average payables | 5.38K | 5.38K | 0 | 0 | 0 | |
Average inventory | 0 | 0 | 0 | 0 | 0 | |
Days sales outstanding | 94.31 | 52.18 | 62.37 | 67.59 | 65.19 | |
Days payables outstanding | 0 | 0 | 0 | 0 | 0 | |
Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
Receivables turnover | 3.87 | 7 | 5.85 | 5.4 | 5.6 | |
Payables turnover | 0 | 0 | 0 | 0 | 0 | |
Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
ROE | -0.12 | 0.18 | 0.14 | 0.17 | -0.24 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
Quarterly Fundamentals Overview
Last date of statement is 2023-06-30 for Q2
Metric | History | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0 | 0 | 0 | 0 | 0 | |
Net income per share | 0 | 0 | 0 | 0 | 0 | |
Operating cash flow per share | 0 | 0 | 0 | 0 | 0 | |
Free cash flow per share | 0 | 0 | 0 | 0 | 0 | |
Cash per share | 0 | 0 | 0 | 0 | 0 | |
Book value per share | 0 | 0 | 0 | 0 | 0 | |
Tangible book value per share | 0 | 0 | 0 | 0 | 0 | |
Share holders equity per share | 0 | 0 | 0 | 0 | 0 | |
Interest debt per share | 0 | 0 | 0 | 0 | 0 | |
Market cap | 0 | 0 | 0 | 0 | 0 | |
Enterprise value | -254.79K | -1.41M | -1.41M | -427.12K | -427.12K | |
P/E ratio | 0 | 0 | 0 | 0 | 0 | |
Price to sales ratio | 0 | 0 | 0 | 0 | 0 | |
POCF ratio | 0 | 0 | 0 | 0 | 0 | |
PFCF ratio | 0 | 0 | 0 | 0 | 0 | |
P/B Ratio | 0 | 0 | 0 | 0 | 0 | |
PTB ratio | 0 | 0 | 0 | 0 | 0 | |
EV to sales | 0 | 0 | 0 | 0 | 0 | |
Enterprise value over EBITDA | 0 | 0 | 0 | 0 | 0 | |
EV to operating cash flow | -0.03 | -0.29 | -0.29 | -0.13 | -0.13 | |
EV to free cash flow | -0.03 | -0.29 | -0.29 | -0.13 | -0.13 | |
Earnings yield | 0 | 0 | 0 | 0 | 0 | |
Free cash flow yield | 0 | 0 | 0 | 0 | 0 | |
Debt to equity | 0 | 0 | 0 | 0 | 0 | |
Debt to assets | 0 | 0 | 0 | 0 | 0 | |
Net debt to EBITDA | 0 | 0 | 0 | 0 | 0 | |
Current ratio | 0.12 | 0.18 | 0.18 | 0.12 | 0.12 | |
Interest coverage | 0 | 0 | 0 | 0 | 0 | |
Income quality | -0.25 | 1.12 | 1.12 | 0.24 | 0.24 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 0 | 0 | 0 | 0 | 0 | |
ROIC | 0 | 0 | 0 | 0 | 0 | |
Return on tangible assets | 0 | 0 | 0 | 0 | 0 | |
Graham Net | 0 | 0 | 0 | 0 | 0 | |
Working capital | -26.33M | -23.68M | -23.68M | -25.87M | -25.87M | |
Tangible asset value | 209.3M | 208.33M | 208.33M | 228.64M | 228.64M | |
Net current asset value | -26.33M | -23.68M | -23.68M | -25.87M | -25.87M | |
Invested capital | 0 | 0 | 0 | 0 | 0 | |
Average receivables | 1.05M | 962.57K | 879.75K | 919.64K | 959.54K | |
Average payables | 0 | 0 | 0 | 0 | 0 | |
Average inventory | 0 | 0 | 0 | 0 | 0 | |
Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
Days payables outstanding | 0 | 0 | 0 | 0 | 0 | |
Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
Payables turnover | 0 | 0 | 0 | 0 | 0 | |
Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
ROE | 0 | 0 | 0 | 0 | 0 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
LZOEX Frequently Asked Questions
What is Lazard Emerging Markets Equity Portfolio Open Shares stock symbol ?
Lazard Emerging Markets Equity Portfolio Open Shares is a US stock and trading under the symbol LZOEX
Is Lazard Emerging Markets Equity Portfolio Open Shares buy or a sell ?
1 stock analysts have 1 predictions with a medium analyst target price of $36. The lowest prediction is $36 and the highest is $36
What is LZOEX stock prediction ?
What is Lazard Emerging Markets Equity Portfolio Open Shares stock quote today ?
Lazard Emerging Markets Equity Portfolio Open Shares stock price is $18.24 today.
Is Lazard Emerging Markets Equity Portfolio Open Shares stock public?
Yes, Lazard Emerging Markets Equity Portfolio Open Shares is a publicly traded company.